PCRX
Pacira BioSciences, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$36.39
+0.00%0
Insider buys (3m)
2
Insider sells (3m)
-$288.5K
Net value (3m)
+34.9%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Oct 9, 2026 | RIKER LAUREN · officer: Senior Vice President, Finance | M-Exempt | 6,000 | $32 |
| Oct 9, 2026 | RIKER LAUREN · officer: Senior Vice President, Finance | Sale | 6,000 | $36 |
| Aug 18, 2026 | SLONIN JONATHAN · officer: Chief Medical Officer | Sale | 3,040 | $23 |
| Jun 12, 2026 | RIKER LAUREN · officer: Senior Vice President, Finance | Sale | 6,115 | $24 |
| Jun 12, 2026 | BIGAL MARCELO · director | A-Award | 10,891 | $23 |
| Jun 12, 2026 | Young Alethia · director | A-Award | 6,405 | $0.00 |
| Jun 12, 2026 | BIGAL MARCELO · director | A-Award | 6,405 | $0.00 |
| Jun 12, 2026 | YANG MICHAEL J. · director | A-Award | 10,891 | $23 |
| Jun 12, 2026 | CHRISTIE CHRISTOPHER · director | A-Award | 10,891 | $23 |
| Jun 12, 2026 | Hirawat Samit · director | A-Award | 6,405 | $0.00 |
| Jun 12, 2026 | WIGGANS THOMAS G · director | A-Award | 32,675 | $23 |
| Jun 12, 2026 | Froimson Mark · director | A-Award | 10,891 | $23 |
| Jun 12, 2026 | Brege Laura · director | A-Award | 6,405 | $0.00 |
| Jun 12, 2026 | Brege Laura · director | A-Award | 10,891 | $23 |
| Jun 12, 2026 | Hirawat Samit · director | A-Award | 10,891 | $23 |
| Jun 12, 2026 | Young Alethia · director | A-Award | 10,891 | $23 |
| Jun 12, 2026 | Froimson Mark · director | A-Award | 6,405 | $0.00 |
| Jun 12, 2026 | YANG MICHAEL J. · director | A-Award | 6,405 | $0.00 |
| Jun 12, 2026 | CHRISTIE CHRISTOPHER · director | A-Award | 6,405 | $0.00 |
| Jun 5, 2026 | SLONIN JONATHAN · officer: Chief Medical Officer | F-InKind | 4,728 | $22 |
| Jun 5, 2026 | RIKER LAUREN · officer: Senior Vice President, Finance | F-InKind | 3,187 | $22 |
| Jun 5, 2026 | WILLIAMS KRISTEN · officer: Chief Administrative Officer | Sale | 10,259 | $22 |
| Jun 5, 2026 | WILLIAMS KRISTEN · officer: Chief Administrative Officer | F-InKind | 8,528 | $22 |
| Apr 24, 2026 | Cross Shawn · officer: Chief Financial Officer | Sale | 12,941 | $25 |
| Apr 24, 2026 | Cross Shawn · officer: Chief Financial Officer | M-Exempt | 12,941 | $16 |
| Apr 22, 2026 | Cross Shawn · officer: Chief Financial Officer | Sale | 1,500 | $25 |
| Apr 22, 2026 | Cross Shawn · officer: Chief Financial Officer | Sale | 7,714 | $25 |
| Apr 22, 2026 | Cross Shawn · officer: Chief Financial Officer | M-Exempt | 2,845 | $16 |
| Apr 22, 2026 | Cross Shawn · officer: Chief Financial Officer | M-Exempt | 1,500 | $16 |
| Apr 22, 2026 | Cross Shawn · officer: Chief Financial Officer | M-Exempt | 7,714 | $16 |
Institutional positioning
13F filings over the trailing two quarters
New 71Increased 172Reduced 177Sold out 27
| Filer | Action | Shares | Filed |
|---|---|---|---|
| BLACKROCK, INC. | Reduced | 6,735,343 | May 13, 2026 |
| BlackRock, Inc. | Reduced | 6,705,809 | Aug 7, 2026 |
| DOMA PERPETUAL CAPITAL MANAGEMENT LLC | Unchanged | 2,777,794 | May 15, 2026 |
| Doma Perpetual Capital Management LLC | Unchanged | 2,777,794 | Aug 12, 2026 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | New Position | 2,501,286 | May 8, 2026 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | Reduced | 2,406,238 | Aug 13, 2026 |
| DIMENSIONAL FUND ADVISORS LP | Increased | 2,103,245 | Aug 11, 2026 |
| DIMENSIONAL FUND ADVISORS LP | Increased | 2,060,597 | May 7, 2026 |
| STATE STREET CORP | Increased | 2,059,977 | Sep 22, 2026 |
| D. E. SHAW & CO., INC. | Reduced | 1,982,724 | May 15, 2026 |
| D. E. Shaw & Co., Inc. | Reduced | 1,950,332 | Aug 14, 2026 |
| STATE STREET CORP | Increased | 1,919,610 | May 15, 2026 |
| RENAISSANCE TECHNOLOGIES LLC | Reduced | 1,825,501 | May 14, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 1,784,049 | May 15, 2026 |
| RENAISSANCE TECHNOLOGIES LLC | Reduced | 1,733,801 | Aug 13, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Oct 9, 2026